You are currently viewing a new version of our website. To view the old version click .
Current Oncology
  • Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
  • Article
  • Open Access

1 August 2015

In Serum, Higher Parathyroid Hormone but Not Lower Vitamin D Is Associated with Oral Squamous Cell Carcinoma

,
,
,
,
,
,
and
1
Department of Endocrinology and Metabolism, The Second Xiangya Hospital, Central South University, Changsha, China
2
Department of Stomatology, The Second Xiangya Hospital, Central South University, Changsha, China
3
Stomatological Hospital of Xiangtan, Xiangtan, China

Abstract

Introduction: Vitamin D and calcium are known to regulate differentiation and proliferation of keratinocytes; they might potentially have a role in suppressing carcinogenesis in squamous epithelium. Serum parathyroid hormone (pth) is a sensitive indicator of calcium and vitamin D deficiency, and 25-hydroxyvitamin D [25(OH)D] is an established marker of vitamin D status. Methods: To determine whether levels of 25(OH)D, calcium, or pth in serum are associated with oral squamous cell carcinoma (oscc), we examined those parameters in serum collected from 70 patients with oscc and from an equal number of matched control subjects. Results: The results showed that intact pth was significantly higher in serum from oscc patients than in serum from control subjects. However, we observed no significant differences in 25(OH)D or calcium in serum from oscc patients and from control subjects. Conclusions: We conclude that higher serum pth, but not lower serum vitamin D or calcium, is associated with oscc.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.